Patents by Inventor Iva Turyan

Iva Turyan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SYSTEMS AND METHODS FOR ASSESSING THERAPEUTIC PROTEINS
    Publication number: 20170276659
    Abstract: Systems and methods for assessing the oxidation status of a pharmaceutical preparations are provided herein. Methods provided herein are particularly useful for assessing pharmaceutical preparations comprising therapeutic proteins (e.g., therapeutic antibodies).
    Type: Application
    Filed: September 4, 2015
    Publication date: September 28, 2017
    Applicant: Biogen MA Inc.
    Inventors: Iva Turyan, Nikhil Khatwani, Zoran Sosic
  • Determination of chromium
    Patent number: 6090269
    Abstract: A highly sensitive assay for the determination of Cr(VI), in the presence of Cr(III) and in the presence of other cations by cyclic voltammetry. The determination is carried out with a gold or gold-plated electrode with a self-assembled monolayer of a pyridine derivative of the kind of 4-(2-ethanethiol) pyridine. Determinations can be affected at extremly low levels of the order of 1 ppt (part per trillion 10.sup.12).
    Type: Grant
    Filed: February 4, 1998
    Date of Patent: July 18, 2000
    Assignee: Yissum Research Development Company of the Hebrew University of Jerusalem
    Inventors: Daniel Mandler, Iva Turyan
  • Determination of ultra low levels of mercury
    Patent number: 5385708
    Abstract: A highly specific and sensitive electrode for the determination of ultra-low levels of mercury and an analytical system based on such electrode. The electrode is a glassy carbon electrode spin-coated with a monolayer of a highly sensitive reagent for the detection of mercury. The analytical method based on the use of this type of electrode is a voltammetric method. Concentrations of the order of as low as about 2.10.sup.-12 Moles mercury can be detected and measured. The reagent is 4,7,13,16,21,24-hexaoxa-1,10-diazabicyclo-[8.8.8]hexacosane.
    Type: Grant
    Filed: July 2, 1993
    Date of Patent: January 31, 1995
    Assignee: Yissum Research Development Company of the Hebrew University of Jerusalem
    Inventors: Daniel Mandler, Iva Turyan